04/18/2024
4:20 PM | TFF Pharmaceuticals (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
04/08/2024
5:41 AM | TFF Pharmaceuticals (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
03/28/2024
3:05 PM | TFF Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2024
3:01 PM | TFF Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/22/2024
7:00 AM | TFF Pharmaceuticals (Filer)
| Form 424B5 | |
02/14/2024
5:48 PM | LYTTON LAURENCE W (Filed by)
TFF Pharmaceuticals (Subject)
| Form SC 13G/A | |
12/19/2023
5:07 AM | TFF Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
12/12/2023
11:15 PM | TFF Pharmaceuticals (Filer)
| Form EFFECT | |
12/08/2023
3:52 PM | TFF Pharmaceuticals (Filer)
| Form S-3/A | |
12/04/2023
4:25 PM | Lee Catherine Chai-zon (Reporting)
TFF Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/04/2023
4:25 PM | Patane Michael A (Reporting)
TFF Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/04/2023
4:26 PM | TFF Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/04/2023
4:27 PM | Lee Catherine Chai-zon (Reporting)
TFF Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/04/2023
4:28 PM | Patane Michael A (Reporting)
TFF Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/04/2023
4:29 PM | ROCAMBOLI STEPHEN (Reporting)
TFF Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/04/2023
4:30 PM | MILLS ROBERT S (Reporting)
TFF Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/04/2023
4:31 PM | Roberts Brandi (Reporting)
TFF Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
4:14 PM | TFF Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/21/2023
3:41 PM | TFF Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
11/14/2023
3:06 PM | TFF Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/22/2023
3:16 PM | TFF Pharmaceuticals (Filer)
| Form PRE 14A | |
09/18/2023
4:20 PM | TFF Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/18/2023
3:10 PM | TFF Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/17/2023
4:27 PM | Asgard Investment Corp. II (Reporting)
CARLSON CAPITAL L P (Reporting)
Carlson Clint Duane (Reporting)
Double Black Diamond Offshore Ltd (Reporting)
TFF Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/17/2023
4:29 PM | Asgard Investment Corp. II (Reporting)
CARLSON CAPITAL L P (Reporting)
Carlson Clint Duane (Reporting)
Double Black Diamond Offshore Ltd (Reporting)
TFF Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2023
3:43 PM | TFF Pharmaceuticals (Filer)
| Form 424B5 | |
08/15/2023
7:00 AM | Mikhak Zamaneh (Reporting)
TFF Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/15/2023
7:00 AM | MILLS ROBERT S (Reporting)
TFF Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/15/2023
7:00 AM | COLEMAN KIRK ALLEN (Reporting)
TFF Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/15/2023
7:00 AM | Roberts Brandi (Reporting)
TFF Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/15/2023
7:00 AM | ROCAMBOLI STEPHEN (Reporting)
TFF Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/15/2023
7:00 AM | TFF Pharmaceuticals (Issuer)
Weisman Harlan F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/15/2023
5:11 AM | TFF Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/27/2023
5:02 AM | TFF Pharmaceuticals (Filer)
| Form 424B5 | |
06/23/2023
4:18 PM | TFF Pharmaceuticals (Filer)
| Form 424B5 | |
06/23/2023
4:15 PM | TFF Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
